First test of new liver drug in healthy people
Knowledge-focused
Completed
This was an early-stage study to see how the body processes a potential new drug called G1090N and to check if it is safe for people. It involved 52 healthy volunteers who received the drug. The main goal was to measure how long the drug stays in the body and to watch for any sid…
Phase: PHASE1 • Sponsor: Genfit • Aim: Knowledge-focused
Last updated Mar 12, 2026 13:51 UTC